Data / Form D filings / EPINEX DIAGNOSTICS INC
EPINEX DIAGNOSTICS INC: Form D filings
EPINEX DIAGNOSTICS INC, a biotechnology company in Tustin, CA, filed 13 Form D notices with the SEC between 2009 and 2016. The latest, on February 10, 2016, reports $100,000 sold of a $100,000 offering to 1 investor.
Find out what EPINEX DIAGNOSTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 14351 MYFORD ROAD, UNIT J, Tustin, CA, 92780
- Phone
- (949) 660-7770
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1309623
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 10, 2016 | New notice | $100,000 | $100,000 | $0 | 1 | Jan 29, 2016 | sec.gov |
| Jan 15, 2016 | Amendment | $3,000,000 | $2,170,092 | $829,908 | 72 | Feb 19, 2013 | sec.gov |
| May 20, 2014 | New notice | $1,000,000 | $200,000 | $800,000 | 2 | May 13, 2014 | sec.gov |
| Aug 2, 2013 | Amendment | $1,668,168 | $318,000 | $1,350,168 | 13 | Feb 19, 2013 | sec.gov |
| Mar 5, 2013 | New notice | $1,668,168 | $318,000 | $1,350,168 | 13 | Feb 19, 2013 | sec.gov |
| Mar 14, 2012 | New notice | $5,000,000 | $50,000 | $4,950,000 | 2 | Mar 1, 2012 | sec.gov |
| Apr 28, 2011 | New notice | $3,000,000 | $202,756 | $2,797,244 | 9 | Apr 15, 2011 | sec.gov |
| Aug 10, 2010 | New notice | $2,040,000 | $598,740 | $1,441,260 | 27 | Jul 26, 2010 | sec.gov |
| Nov 13, 2009 | Amendment | $15,015,000 | $1,174,857 | $13,840,143 | 41 | Apr 17, 2008 | sec.gov |
| Nov 3, 2009 | Amendment | $15,015,000 | $1,164,857 | $13,850,143 | 40 | Apr 17, 2008 | sec.gov |
| Jul 15, 2009 | Amendment | $15,015,000 | $1,119,857 | $13,895,143 | 38 | Apr 17, 2008 | sec.gov |
| Jun 12, 2009 | Amendment | $15,015,000 | $1,074,257 | $13,940,743 | 35 | Apr 17, 2008 | sec.gov |
| Apr 21, 2009 | Amendment | $15,015,000 | $1,019,017 | $13,995,983 | 33 | Apr 17, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Asad Zaidi | Executive Officer, Director | |
| Azra Zaidi | Director | |
| Henry Smith | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of Feb 8, 2016 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EPINEX DIAGNOSTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.